Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

OBJECTIVES: To compare 1-year clinical efficacy of (1) initial triple disease-modifying antirheumatic drug therapy (iTDT) with initial methotrexate (MTX) monotherapy (iMM) and (2) different glucocorticoid (GC) bridging therapies: oral versus a single intramuscular injection in early rheumatoid arthr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, P H, Hazes, J M, Han, H K, Huisman, M, van Zeben, D, van der Lubbe, P A, Gerards, A H, van Schaeybroeck, B, de Sonnaville, P B, van Krugten, M V, Luime, J J, Weel, A E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078755/
https://www.ncbi.nlm.nih.gov/pubmed/24788619
http://dx.doi.org/10.1136/annrheumdis-2013-204788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078755/
https://www.ncbi.nlm.nih.gov/pubmed/24788619
http://dx.doi.org/10.1136/annrheumdis-2013-204788

Ejemplares similares